Skip to content

July 2026: Government declines to widen the Thirlwall terms of reference (16 July) · new 100-page insulin report to the CCRC challenging the trial evidence (9 July) · Thirlwall report still expected no earlier than September · inquests relisted to 2027 · Shoo Lee Panel: no medical evidence of deliberate harm.

Lucy Letby Facts
Editorial summary (not a verbatim transcript)
2025·Mount Sinai Hospital Toronto; University of Toronto Department of Paediatrics

Mount Sinai Hospital Toronto — institutional position

A summary of the institutional position that has emerged from Mount Sinai Hospital Toronto and the University of Toronto Department of Paediatrics in support of the Shoo Lee Panel's findings. Dr Shoo Lee, Prof. Prakesh Shah (his successor as paediatrician-in-chief) and Prof. Douglas Campbell all sit on the Panel. The institutional coherence of the Mount Sinai / Toronto position demonstrates the Panel's finding is not a single-senior-clinician intervention but the continuing position of a flagship North American neonatal programme.

XBlueskyFacebookLinkedInWhatsAppRedditMastodonEmail
Last updated

Editorial summary — not a verbatim transcript.

This page is a summary written for this site. It is not a mirror of the primary document, and nothing on it should be quoted as the words of any person. An earlier version of this page carried quotations that could not be verified against the primary record; those have been removed. For the underlying record, consult the primary source at lucyletbyinnocence.com. See our corrections policy.

Status: Editorial summary written for this site — not a mirrored document

Publisher: lucyletbyinnocence.comThis links the publisher’s site, not the document itself — we have not yet established a direct link to it.

Context

Mount Sinai Hospital Toronto is one of North America’s flagship neonatal programmes. Three of its past and present senior neonatologists sit on the Shoo Lee International Expert Panel: Dr Shoo Lee himself (former paediatrician-in-chief), Prof. Prakesh Shah (his successor in that role), and Prof. Douglas Campbell. The institutional coherence of the Panel’s finding is visible in this triple-signature from a single flagship programme.

Why institutional coherence matters

A finding signed by one senior clinician, however distinguished, could be described as an individual judgement. A finding signed by the former paediatrician-in-chief, the current paediatrician-in-chief, and another senior Associate Professor from the same institution is structurally different. It represents an institutional position of a major neonatal programme.

The Mount Sinai Toronto position on the Letby medical evidence is not that one senior clinician happens to disagree with the Crown’s experts. It is that the continuing institutional reading of one of North America’s leading neonatal programmes is that the medical evidence of deliberate harm is not present in the Letby casebook.

The University of Toronto context

The University of Toronto Department of Paediatrics is one of the largest and most research-active paediatrics departments in North America. Its neonatology division produces substantial peer-reviewed research and operates the Canadian Neonatal Network outcomes registry (under Prof. Shah’s leadership). The UofT institutional frame on neonatal clinical reasoning is therefore a well-developed one.

What the Toronto signatories add

  • Dr Shoo Lee: author of the 1989 air-embolism paper cited by the Crown; Panel chair; public-facing voice of the Panel’s position.
  • Prof. Prakesh Shah: paediatrician-in-chief; director of the Canadian Neonatal Network; population-outcomes calibration.
  • Prof. Douglas Campbell: Associate Professor at the University of Toronto; additional clinical-neonatology perspective.

Read alongside

Dr Shoo Lee — biography, Prof. Prakesh Shah — biography, Panel members — full list, Panel press conference (Feb 2025).

Related on this site

Evidence issues

Share:XBlueskyFacebookLinkedInWhatsAppRedditMastodonEmail